Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis
Autor: | Xue-Li Niu, Yu Huang, Ya-Li Gao, Yu-Zhe Sun, Yang Han, Hong-Duo Chen, Xing-Hua Gao, Rui-Qun Qi, Yuan-Yuan Ji |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Chinese Medical Journal, Vol 132, Iss 6, Pp 690-698 (2019) |
Druh dokumentu: | article |
ISSN: | 0366-6999 2542-5641 00000000 |
DOI: | 10.1097/CM9.0000000000000140 |
Popis: | Abstract. Background:. As a potent pro-inflammatory cytokine of the interleukin (IL)-1 family, IL-18 was elevated in early active and progressive plaque-type psoriatic lesions and that serum or plasma levels of IL-18 correlated with the Psoriasis Area and Severity Index (PASI). Although results from previous studies have established that IL-18 may aggravate psoriatic inflammation, the mechanisms of this process remain unknown. In this study, IL-18 knock out (KO) mice and wild-type (WT) mice were used to investigate the effects of IL-18 within a mouse model of psoriasis. Methods:. WT and IL-18 KO mice were divided into four groups, including imiquimod (IMQ)-treated IL-18 KO group (n = 11) and WT group (n = 13) as well as their respectively gene-matched control mice (receiving vaseline; n = 12). PASI scores were used to evaluate psoriatic lesions in IMQ-treated mice. Pathological features and dermal cellular infiltration were investigated by hematoxylin and eosin staining. The levels of psoriasis-related cytokines including IL-23, IL-17, IL-12, IL-1β, IFNγ, IL-15, IL-27, and IL-4 were tested by real-time polymerase chain reaction (PCR). The protein level of IL-1β, IL-27, CXCL1, and Ly6 g were investigated by immunohistochemistry (IHC). Results:. Acanthosis (98.46 ± 14.12 vs. 222.68 ± 71.10 μm, P |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |